Navigation Links
New Portable, Cost-effective Agile R100 Detects Zika Viral Protein with High Sensitivity and Specificity
Date:9/12/2017

Nanomedical Diagnostics, a cutting-edge life science company pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces a new publication in Biosensors and Bioelectronics demonstrating detection of Zika viral antigen using the label-free Agile R100 biosensor. Antibodies developed by the Centers for Disease Control (CDC) were used to directly detect the viral protein Zika NS1 at clinically relevant levels of sensitivity. Specificity to Zika NS1 was demonstrated with no sensor response to Japanese Encephalitis NS1, a closely-related infection that potentially produces false positives.

The Zika virus, a mosquito-borne infection, has been shown to be a cause of microcephaly and other severe fetal brain defects. For pregnant women, it is especially important to reliably identify Zika virus infection in a timely manner, but current methods show high false positive rates and can take weeks to return test results. The compact and portable Agile R100 represents a potential methodology to identify Zika infection promptly.

“Diagnosing Zika infection early and accurately is a high priority,” says Nanomedical Diagnostics CEO, Ross Bundy. “Families need to make decisions about pregnancy, additional testing, and healthcare based on the test results they receive, and the current IgM serology test used to diagnose the disease has a false positive rate of over 50%. The test to confirm the IgM serology result, the plaque reduction neutralization test (PRNT), can only be run by the CDC and can take up to six weeks to return, causing enormous anxiety during what should be a happy time. Agile R100 demonstrated detection of Zika virus at a level that potentially allows the disease to be identified within three days of infection. Because Agile R100 is cost-effective, easy to use, and portable, it can be run by the healthcare provider, and results can be returned immediately. And the peer-reviewed study showed no cross-reactivity with Japanese Encephalitis, a potentially confounding disease that could cause false positives. The Agile R100 biosensor is a promising platform for Zika clinical application development, with the potential for improving diagnostic testing in the early-infection stage.”

Agile R100 is a portable label-free graphene biosensor designed to provide information-rich data for drug discovery. The proprietary Field Effect Biosensing (FEB) technology on which it is based is an electrical technique that enables cost-effective, robust, portable form factors that can be applied in life science research, drug discovery applications, and diagnostic and health monitoring platforms.

About Nanomedical Diagnostics

Nanomedical Diagnostics (“Nanomed”) is a life science company based in San Diego, CA. Nanomed has developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that delivers sensitive real-time direct detection of biomolecules. As the world’s only mass-manufacturer of graphene biosensors, Nanomed’s mission is to transform the healthcare industry with innovative new products that enable cutting-edge life science research, drug discovery applications, and portable diagnostic and health monitoring platforms.

Read the full story at http://www.prweb.com/releases/Nanomedical_Diagnostics/Zika_virus_detection/prweb14684715.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Agena Bioscience and CapitalBio Technology to Develop Cost-Effective Genetic Testing for Commercial Agricultural Applications
2. MMIS Partners With Healthcare Data Solutions To Deliver New, Cost-Effective Aggregate Spend Technology
3. Live Webinar on Safe and Cost-Effective Capsule Filling
4. Cost-effective, solvothermal synthesis of heteroatom (S or N)-doped graphene developed
5. Worcester Polytechnic Institute Receives NIH Grant to Study Components of a Potentially Potent and Cost-Effective Malaria Treatment
6. Annai Systems Expands Access to GTFuse for Rapid and Cost-effective Use of Sequencing Data
7. SoundConnect Responds to Increased, Cost-Effective Unified Communications Demands Through Agent Partnership Program
8. Core and More Technologies Announces the Most Comprehensive and Cost-effective Paid Search Advertising Packages Available in the Industry Today
9. Proscia Provides Agilent Technologies with Digital Pathology Platform for Interactive Version of the Dako Atlas of Stains
10. Nanomedical Diagnostics Launches New Agile Biosensor to Accelerate Label-free Drug Development
11. Agilent Offers Clinical Research Applications of Accelerated Data Workflows for Biomarker Discovery in Cystic Fibrosis Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... ... October 06, 2017 , ... ... ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C kit. ... to perform Hi-C metagenome deconvolution using their own facilities, supplementing the company’s ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... healthcare and technology sector at their fourth annual Conference where founders, investors, innovative ... speakers and the ELEVATE pitch competition showcasing early stage digital health and med ...
(Date:10/5/2017)... ... 05, 2017 , ... LabRoots , the leading provider of educational and ... giving back to cancer research with a month-long promotion supporting the advancement of breast ... shoppers can use promo code PinkRibbon to get 10 percent off their purchase of ...
(Date:10/5/2017)... ... 2017 , ... NIH has awarded Circulomics two SBIR grants ... technology . Nanobind is a novel magnetic disk that contains a high density ... for a wide variety of sample preparation applications. The nanostructured surface provides high ...
Breaking Biology Technology:
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
Breaking Biology News(10 mins):